title: Food restriction increases acquisition, persistence and drug prime-induced expression of a cocaine-conditioned place preference in rats.
abstract: Cocaine conditioned place preference (CPP) is more persistent in food-restricted than ad libitum fed rats. This study assessed whether food restriction acts during conditioning and/or expression to increase persistence. In Experiment 1, rats were food-restricted during conditioning with a 7.0 mg/kg (i.p.) dose of cocaine. After the first CPP test, half of the rats were switched to ad libitum feeding for three weeks, half remained on food restriction, and this was followed by CPP testing. Rats tested under the ad libitum feeding condition displayed extinction by the fifth test. Their CPP did not reinstate in response to overnight food deprivation or a cocaine prime. Rats maintained on food restriction displayed a persistent CPP. In Experiment 2, rats were ad libitum fed during conditioning with the 7.0 mg/kg dose. In the first test only a trend toward CPP was displayed. Rats maintained under the ad libitum feeding condition did not display a CPP during subsequent testing and did not respond to a cocaine prime. Rats tested under food-restriction also did not display a CPP, but expressed a CPP following a cocaine prime. In Experiment 3, rats were ad libitum fed during conditioning with a 12.0 mg/kg dose. After the first test, half of the rats were switched to food restriction for three weeks. Rats that were maintained under the ad libitum condition displayed extinction by the fourth test. Their CPP was not reinstated by a cocaine prime. Rats tested under food-restriction displayed a persistent CPP. These results indicate that food restriction lowers the threshold dose for cocaine CPP and interacts with a previously acquired CPP to increase its persistence. In so far as CPP models Pavlovian conditioning that contributes to addiction, these results suggest the importance of diet and the physiology of energy balance as modulatory factors.
authors.affiliation: Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA.
authors.forename: Danielle
authors.initials: D
authors.lastname: Zheng
authors.forename: Soledad
authors.initials: S
authors.lastname: Cabeza de Vaca
authors.forename: Kenneth D
authors.initials: KD
authors.lastname: Carr
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D031204:Caloric Restriction / Q000009:adverse effects*; D003042:Cocaine / Q000008:administration & dosage / Q000494:pharmacology; D019970:Cocaine-Related Disorders / Q000178:diet therapy / Q000503:physiopathology* / Q000517:prevention & control / Q000523:psychology; D003213:Conditioning, Psychological; D004305:Dose-Response Relationship, Drug; D002149:Energy Intake; D005106:Exploratory Behavior / Q000187:drug effects; D005108:Extinction, Psychological; D008297:Male; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012054:Reinforcement, Psychology; D055502:Secondary Prevention
chemical_list: D003042:Cocaine
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3191-200
references.pmid: 18640912
references.citation: Physiol Behav. 2010 Jul 14;100(5):419-28
references.pmid: 20338186
references.citation: Ann N Y Acad Sci. 1992 Jun 28;654:400-15
references.pmid: 1632593
references.citation: Brain Res. 2008 Apr 14;1204:94-101
references.pmid: 18342839
references.citation: Nat Neurosci. 2005 May;8(5):555-60
references.pmid: 15856062
references.citation: NIDA Res Monogr. 1988;81:74-80
references.pmid: 3136393
references.citation: J Youth Adolesc. 2009 Nov;38(10):1364-73
references.pmid: 19779812
references.citation: Brain Res Mol Brain Res. 2005 Nov 30;141(2):121-7
references.pmid: 16257473
references.citation: Psychopharmacology (Berl). 2011 Dec;218(4):693-701
references.pmid: 21629996
references.citation: J Neurosci. 1995 Nov;15(11):7181-8
references.pmid: 7472472
references.citation: Brain Res. 2003 Feb 21;964(1):107-15
references.pmid: 12573518
references.citation: Neuron. 2005 Sep 15;47(6):873-84
references.pmid: 16157281
references.citation: J Neurosci. 1998 Sep 15;18(18):7502-10
references.pmid: 9736668
references.citation: Brain Res. 2011 Jul 11;1400:31-41
references.pmid: 21640333
references.citation: Pharmacol Biochem Behav. 2007 Nov;88(1):89-93
references.pmid: 17764729
references.citation: Behav Brain Res. 2009 Jun 8;200(1):134-43
references.pmid: 19373979
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46
references.pmid: 18640920
references.citation: Behav Neurosci. 2006 Apr;120(2):401-12
references.pmid: 16719704
references.citation: Curr Opin Neurobiol. 2004 Apr;14(2):156-62
references.pmid: 15082319
references.citation: Annu Rev Neurosci. 2006;29:565-98
references.pmid: 16776597
references.citation: Psychopharmacology (Berl). 2000 Oct;152(2):200-7
references.pmid: 11057524
references.citation: Physiol Behav. 2002 Jul;76(3):353-64
references.pmid: 12117572
references.citation: Int J Neurosci. 2009;119(2):291-304
references.pmid: 19125380
references.citation: J Neurosci. 2006 Oct 25;26(43):11041-51
references.pmid: 17065446
references.citation: Behav Brain Res. 2000 Oct;115(1):39-47
references.pmid: 10996406
references.citation: J Mol Neurosci. 2001 Feb;16(1):1-12
references.pmid: 11345515
references.citation: Eur J Neurosci. 2006 Oct;24(7):2089-97
references.pmid: 17067306
references.citation: Psychopharmacology (Berl). 2001 Mar;154(3):311-8
references.pmid: 11351938
references.citation: Addict Behav. 1998 Mar-Apr;23(2):201-7
references.pmid: 9573424
references.citation: Int J Obes (Lond). 2009 Jun;33 Suppl 2:S25-9
references.pmid: 19528975
references.citation: Brain Res. 1996 Jun 17;724(2):251-5
references.pmid: 8828576
references.citation: Science. 1979 Jul 20;205(4403):319-21
references.pmid: 36665
references.citation: J Neurosci. 2001 Feb 15;21(4):RC129
references.pmid: 11160414
references.citation: Psychopharmacology (Berl). 2008 Aug;199(2):169-82
references.pmid: 18551281
references.citation: J Clin Invest. 2006 Dec;116(12):3229-39
references.pmid: 17060947
references.citation: Psychopharmacology (Berl). 1997 May;131(1):1-8
references.pmid: 9181629
references.citation: Brain Res. 2006 Apr 12;1082(1):98-101
references.pmid: 16516172
references.citation: J Neurosci. 2002 May 1;22(9):3306-11
references.pmid: 11978804
references.citation: Physiol Behav. 2007 Aug 15;91(5):459-72
references.pmid: 17081571
references.citation: Int J Eat Disord. 2010 Jan;43(1):14-21
references.pmid: 19260043
references.citation: Physiol Behav. 2005 Sep 15;86(1-2):9-10
references.pmid: 16129462
references.citation: Behav Neurosci. 2008 Dec;122(6):1257-63
references.pmid: 19045945
references.citation: Neuropsychopharmacology. 2008 Jan;33(1):166-80
references.pmid: 17805308
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6772-7
references.pmid: 19342492
references.citation: Brain Res. 1995 Oct 30;697(1-2):76-82
references.pmid: 8593597
references.citation: Addict Biol. 2007 Mar;12(1):22-9
references.pmid: 17407494
references.citation: Eur J Neurosci. 2005 Mar;21(5):1385-93
references.pmid: 15813948
references.citation: J Neurochem. 2008 Aug;106(4):1780-90
references.pmid: 18554320
references.citation: Biol Psychiatry. 2011 Jul 15;70(2):204-7
references.pmid: 21215388
references.citation: Neuropharmacology. 2011 Dec;61(7):1123-8
references.pmid: 21420985
references.citation: Tob Control. 1997 Summer;6(2):89-94
references.pmid: 9291216
references.citation: Neuroreport. 2005 Jul 13;16(10):1129-33
references.pmid: 15973161
references.citation: Brain Res. 2006 May 4;1087(1):123-33
references.pmid: 16600190
references.citation: Neuroscience. 2004;125(1):289-98
references.pmid: 15051167
references.citation: Int J Eat Disord. 2008 Jul;41(5):464-70
references.pmid: 18348283
references.citation: Neuroscience. 2010 Feb 17;165(4):1074-86
references.pmid: 19931598
references.citation: Synapse. 2002 Nov;46(2):83-90
references.pmid: 12211086